Cynthia J. Curry
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cynthia J. Curry has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
C. Dawn Delozier
1 shared publicationEdward J. Lammer
Children's Hospital, Oakland Research Institute, Oakland, California
1 shared publicationElizabeth R Roeder
Genetic Medicine, Valley Children's Hospital/UCSF, Madera
1 shared publicationElizabeth R. Roeder
1 shared publicationGary M. Shaw
California Birth Defects Monitoring Program, Berkeley, California
1 shared publicationH. Terry Hutchison
1 shared publication
Latest Publications
- 23 October 2008
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 359 (17) , 1857-1858
Book Review DNA: Promise and Peril By Linda L. McCabe and Edward R.B. McCabe. 339 pp., illustrated. Berkeley, University of California Press, 2008. $39.95. 978-0-520-25187-8
Recent progress in human and medical genetics has been nothing short of astonishing in its breadth, complexity, and speed. There have been few comprehensive reviews of the ethical and social issues that are posed by achievements in the field, particularly those that came after the completion of the Human Genome Project. DNA: Promise and Peril goes a long way toward exploring these issues in a painstaking yet readable scholarly treatise. The McCabes bring to this rather daunting endeavor their considerable experience in research, political activism, program development, and teaching. Throughout, they make a convincing case that we are not our genome alone, and they firmly reject the popularly held thesis of genetic determinism.
- 23 October 2008
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 359 (17) , 1857-1858
Book Review DNA: Promise and Peril By Linda L. McCabe and Edward R.B. McCabe. 339 pp., illustrated. Berkeley, University of California Press, 2008. $39.95. 978-0-520-25187-8
Recent progress in human and medical genetics has been nothing short of astonishing in its breadth, complexity, and speed. There have been few comprehensive reviews of the ethical and social issues that are posed by achievements in the field, particularly those that came after the completion of the Human Genome Project. DNA: Promise and Peril goes a long way toward exploring these issues in a painstaking yet readable scholarly treatise. The McCabes bring to this rather daunting endeavor their considerable experience in research, political activism, program development, and teaching. Throughout, they make a convincing case that we are not our genome alone, and they firmly reject the popularly held thesis of genetic determinism.
- 1 August 2007
- Published by Elsevier in Pediatric Neurology
- Vol. 37 (2) , 99-107
Risk Factors for Perinatal Arterial Stroke: A Study of 60 Mother-Child Pairs
- 1 August 2007
- Published by Elsevier in Pediatric Neurology
- Vol. 37 (2) , 99-107
Risk Factors for Perinatal Arterial Stroke: A Study of 60 Mother-Child Pairs
- 20 September 2005
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 138A (3) , 303
Book review
- 20 September 2005
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 138A (3) , 303
Book review
- 29 July 2005
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 137A (2) , 181-189
Schizencephaly: Heterogeneous etiologies in a population of 4 million California births
Schizencephaly is a rare congenital brain defect characterized by gray matter lined clefts of the cerebral mantle, frequently accompanied by other defects of the CNS such as absence of the corpus callosum. This study in a California population of >4 million births from 1985–2001 found a population prevalence of 1.54/100,000. Among 63 cases, there was an association with young parental age in isolated schizencephaly (RR 3.9 mothers; 5.8 fathers), which was also seen in mothers but not fathers of non‐isolated cases (RR 3.2). Monozygotic twins may also be at increased risk for schizencephaly (RR 2.1). One third of cases had a non‐CNS abnormality, over half of which could be classified as secondary to vascular disruption, including gastroschisis, bowel atresias, and amniotic band disruption sequence. Other apparent rare causes included chromosomal aneuploidy, non‐random associations, and unusual syndromes. Our observations suggest that schizencephaly has heterogeneous etiologies many of which are vascular disruptive in origin.
- 29 July 2005
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 137A (2) , 181-189
Schizencephaly: Heterogeneous etiologies in a population of 4 million California births
Schizencephaly is a rare congenital brain defect characterized by gray matter lined clefts of the cerebral mantle, frequently accompanied by other defects of the CNS such as absence of the corpus callosum. This study in a California population of >4 million births from 1985–2001 found a population prevalence of 1.54/100,000. Among 63 cases, there was an association with young parental age in isolated schizencephaly (RR 3.9 mothers; 5.8 fathers), which was also seen in mothers but not fathers of non‐isolated cases (RR 3.2). Monozygotic twins may also be at increased risk for schizencephaly (RR 2.1). One third of cases had a non‐CNS abnormality, over half of which could be classified as secondary to vascular disruption, including gastroschisis, bowel atresias, and amniotic band disruption sequence. Other apparent rare causes included chromosomal aneuploidy, non‐random associations, and unusual syndromes. Our observations suggest that schizencephaly has heterogeneous etiologies many of which are vascular disruptive in origin.
- 1 April 1999
- Published by Springer Nature in Pediatric Research
- Vol. 45 (4, Part 2 ) , 340A
Thrombophilic Factors in Neonatal Stroke
- 1 April 1999
- Published by Springer Nature in Pediatric Research
- Vol. 45 (4, Part 2 ) , 340A
Thrombophilic Factors in Neonatal Stroke